痴呆相关行为症状的药物治疗管理。
Pharmacological management of behavioral symptoms associated with dementia.
机构信息
Subramoniam Madhusoodanan, Department of Psychiatry, SUNY Downstate Medical Center, Brooklyn, NY 11203, United States.
出版信息
World J Psychiatry. 2014 Dec 22;4(4):72-9. doi: 10.5498/wjp.v4.i4.72.
Abstract
Dementia is a clinical syndrome with features of neurocognitive decline. Subtypes of dementia include Alzheimer's, frontotemporal, Parkinson's, Lewy body disease, and vascular type. Dementia is associated with a variety of neuropsychiatric symptoms that may include agitation, psychosis, depression, and apathy. These symptoms can lead to dangerousness to self or others and are the main source for caregiver burnout. Treatment of these symptoms consists of nonpharmacological and pharmacological interventions. However, there are no Food and Drug Administration-approved medications for the treatment of behavioral and psychological symptoms of dementia. Pharmacological interventions are used off-label. This article reviews the current evidence supporting or negating the use of psychotropic medications along with safety concerns, monitoring, regulations, and recommendations.
摘要
痴呆是一种以神经认知功能下降为特征的临床综合征。痴呆的亚型包括阿尔茨海默病、额颞叶痴呆、帕金森病、路易体病和血管性痴呆。痴呆与各种神经精神症状相关，可能包括激越、精神病、抑郁和淡漠。这些症状可能导致自我或他人的危险，是导致照顾者精疲力竭的主要原因。这些症状的治疗包括非药物和药物干预。然而，目前还没有获得美国食品和药物管理局批准的用于治疗痴呆的行为和心理症状的药物。药物干预是在标签外使用的。本文综述了目前支持或否定使用精神药物治疗痴呆的行为和心理症状的证据，同时还讨论了安全性问题、监测、法规和建议。
相似文献
1
Pharmacological management of behavioral symptoms associated with dementia.痴呆相关行为症状的药物治疗管理。
World J Psychiatry. 2014 Dec 22;4(4):72-9. doi: 10.5498/wjp.v4.i4.72.
2
Pharmacotherapy of Behavioral and Psychological Symptoms of Dementia: State of the Art and Future Progress.痴呆行为和心理症状的药物治疗：现状与未来进展
Front Pharmacol. 2020 Jul 31;11:1168. doi: 10.3389/fphar.2020.01168. eCollection 2020.
3
Management of Behavioral and Psychological Symptoms of Dementia.痴呆症行为和心理症状的管理
Noro Psikiyatr Ars. 2014 Dec;51(4):303-312. doi: 10.5152/npa.2014.7405. Epub 2014 Dec 1.
5
Caregiver burden, sleep quality, depression, and anxiety in dementia caregivers: a comparison of frontotemporal lobar degeneration, dementia with Lewy bodies, and Alzheimer's disease.痴呆症照顾者的负担、睡眠质量、抑郁和焦虑：额颞叶变性、路易体痴呆和阿尔茨海默病的比较。
Int Psychogeriatr. 2018 Aug;30(8):1131-1138. doi: 10.1017/S1041610217002630. Epub 2017 Dec 10.
7
The Use of Risperidone in Behavioral and Psychological Symptoms of Dementia: A Review of Pharmacology, Clinical Evidence, Regulatory Approvals, and Off-Label Use.利培酮在痴呆行为和心理症状中的应用：药理学、临床证据、监管批准及超说明书用药综述
Front Pharmacol. 2020 May 20;11:596. doi: 10.3389/fphar.2020.00596. eCollection 2020.
8
Behavioral and psychological symptoms in Alzheimer's dementia and vascular dementia.阿尔茨海默病性痴呆和血管性痴呆中的行为及心理症状
Handb Clin Neurol. 2019;165:5-32. doi: 10.1016/B978-0-444-64012-3.00002-2.
9
Management of neuropsychiatric symptoms of dementia in clinical settings: recommendations from a multidisciplinary expert panel.临床环境中痴呆的神经精神症状管理：多学科专家小组的建议。
J Am Geriatr Soc. 2014 Apr;62(4):762-9. doi: 10.1111/jgs.12730. Epub 2014 Mar 17.
10
Behavioral or neuropsychiatric symptoms of Alzheimer's disease: from psychopathology to pharmacological management.阿尔茨海默病的行为或神经精神症状：从精神病理学到药物治疗管理。
Arq Neuropsiquiatr. 2023 Dec;81(12):1152-1162. doi: 10.1055/s-0043-1777774. Epub 2023 Dec 29.
引用本文的文献
1
Differences in pharmacologic and demographic factors in male and female patients with vascular dementia, Alzheimer's disease, and mixed vascular dementia.血管性痴呆、阿尔茨海默病和混合性血管性痴呆的男性和女性患者在药理学和人口统计学因素上的差异。
Front Dement. 2023 Jun 30;2:1137856. doi: 10.3389/frdem.2023.1137856. eCollection 2023.
2
Diagnosis of behavioral symptoms as a predictor of institutionalization among Medicaid patients with dementia.以行为症状为指标预测接受医疗补助的痴呆患者的机构化。
BMC Geriatr. 2023 Dec 5;23(1):807. doi: 10.1186/s12877-023-04506-9.
3
Clinical Efficacy of Deep Transcranial Magnetic Stimulation in Psychiatric and Cognitive Disorders: Protocol for a Systematic Review.深部经颅磁刺激治疗精神和认知障碍的临床疗效：系统评价方案
JMIR Res Protoc. 2023 May 26;12:e45213. doi: 10.2196/45213.
4
Efficacy difference of antipsychotics in Alzheimer's disease and schizophrenia: explained with network efficiency and pathway analysis methods.抗精神病药在阿尔茨海默病和精神分裂症中的疗效差异：用网络效率和途径分析方法解释。
Brief Bioinform. 2022 Nov 19;23(6). doi: 10.1093/bib/bbac394.
5
Development of Synergy-Based Combination for Learning and Memory Using , and TLC-MS-Bioautographic Studies.基于协同作用的学习与记忆组合的开发及使用、和薄层色谱-质谱联用生物自显影研究
Front Pharmacol. 2021 Jul 2;12:678611. doi: 10.3389/fphar.2021.678611. eCollection 2021.
6
Predicting the Severity of Parkinson's Disease Dementia by Assessing the Neuropsychiatric Symptoms with an SVM Regression Model.采用 SVM 回归模型评估神经精神症状预测帕金森病痴呆的严重程度。
Int J Environ Res Public Health. 2021 Mar 4;18(5):2551. doi: 10.3390/ijerph18052551.
7
Creating a toolkit with stakeholders for leveraging tablet computers to support person-centred dementia care in hospitals.与利益相关者共同创建一个工具包，以利用平板电脑在医院支持以患者为中心的痴呆症护理。
J Rehabil Assist Technol Eng. 2020 Nov 23;7:2055668320960385. doi: 10.1177/2055668320960385. eCollection 2020 Jan-Dec.
8
Agitation and impulsivity in mid and late life as possible risk markers for incident dementia.中年及老年期的激越和冲动可能是新发痴呆症的风险标志物。
Alzheimers Dement (N Y). 2020 Sep 6;6(1):e12016. doi: 10.1002/trc2.12016. eCollection 2020.
9
Quetiapine and novel PDE10A inhibitors potentiate the anti-BuChE activity of donepezil.喹硫平和新型 PDE10A 抑制剂增强了多奈哌齐的抗 BuChE 活性。
J Enzyme Inhib Med Chem. 2020 Dec;35(1):1743-1750. doi: 10.1080/14756366.2020.1818739.
10
Prevalence and persistent use of psychotropic drugs in older adults receiving domiciliary care at baseline.在基线时，接受家庭护理的老年人中精神药物的流行情况和持续使用情况。
BMC Geriatr. 2019 Apr 25;19(1):119. doi: 10.1186/s12877-019-1126-y.
本文引用的文献
1
Effects of Buspirone on Agitation Associated With Dementia.
Am J Geriatr Psychiatry. 1993;1(1):82-84. doi: 10.1097/00019442-199300110-00011. Epub 2013 Jan 28.
2
Buspirone in the Management of Agitation and Aggression Associated With Dementia.
Am J Geriatr Psychiatry. 1993;1(3):249-253. doi: 10.1097/00019442-199300130-00010. Epub 2013 Jan 28.
3
Efficacy and tolerability of benzodiazepines for the treatment of behavioral and psychological symptoms of dementia: a systematic review of randomized controlled trials.苯二氮䓬类药物治疗痴呆行为和心理症状的疗效及耐受性：随机对照试验的系统评价
Am J Alzheimers Dis Other Demen. 2014 Nov;29(7):565-74. doi: 10.1177/1533317514524813.
4
Effect of citalopram on agitation in Alzheimer disease: the CitAD randomized clinical trial.西酞普兰对阿尔茨海默病激越的影响：CitAD 随机临床试验。
JAMA. 2014 Feb 19;311(7):682-91. doi: 10.1001/jama.2014.93.
5
Short- and long-term mortality risk associated with the use of antipsychotics among 26,940 dementia outpatients: a population-based study.26940例痴呆门诊患者使用抗精神病药物的短期和长期死亡风险：一项基于人群的研究
Am J Geriatr Psychiatry. 2014 Apr;22(4):321-31. doi: 10.1016/j.jagp.2013.06.007. Epub 2013 Sep 7.
6
The long-term effects of conventional and atypical antipsychotics in patients with probable Alzheimer's disease.可能患有阿尔茨海默病的患者中，常规和非典型抗精神病药物的长期影响。
Am J Psychiatry. 2013 Sep;170(9):1051-8. doi: 10.1176/appi.ajp.2013.12081046.
7
Psychosis of Alzheimer disease: prevalence, incidence, persistence, risk factors, and mortality.阿尔茨海默病的精神病性症状：患病率、发病率、持续性、危险因素和死亡率。
Am J Geriatr Psychiatry. 2013 Nov;21(11):1135-43. doi: 10.1016/j.jagp.2013.01.051. Epub 2013 Feb 6.
8
Aripiprazole in the treatment of Alzheimer's disease.阿立哌唑治疗阿尔茨海默病。
Expert Opin Pharmacother. 2013 Mar;14(4):459-74. doi: 10.1517/14656566.2013.764989. Epub 2013 Jan 28.
9
Relapse risk after discontinuation of risperidone in Alzheimer's disease.阿兹海默病患者停用利培酮后的复发风险。
N Engl J Med. 2012 Oct 18;367(16):1497-507. doi: 10.1056/NEJMoa1114058.
10
Antipsychotic use and mortality risk in community-dwelling Alzheimer's disease patients: evidence for a role of dementia severity.抗精神病药物的使用与社区居住的阿尔茨海默病患者的死亡风险：痴呆严重程度的作用证据。
Curr Alzheimer Res. 2012 Nov;9(9):1106-16. doi: 10.2174/156720512803569037.
Zotero 插件